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Although the cellular prion protein (PrPC) is concentrated at
synapses, the factors that target PrPC to synapses are not under-
stood. Here we demonstrate that exogenous PrPC was rapidly
targeted to synapses in recipient neurons derived from Prnp
knock-out(0/0) mice. The targeting of PrPC to synapses was de-
pendent uponbothneuronal cholesterol concentrations and the
lipid and glycan composition of its glycosylphosphatidylinositol
(GPI) anchor. Thus, the removal of either an acyl chain or sialic
acid from the GPI anchor reduced the targeting of PrPC to syn-
apses. Isolated GPIs (derived from PrPC) were also targeted to
synapses, as was IgG conjugated to these GPIs. The removal of
sialic acid from GPIs prevented the targeting of either the iso-
lated GPIs or the IgG-GPI conjugate to synapses. Competition
studies showed that pretreatment with sialylated GPIs pre-
vented the targeting of PrPC to synapses. These results are con-
sistent with the hypothesis that the sialylated GPI anchor
attached to PrPC acts as a synapse homing signal.
The cellular prion protein (PrPC)2 gained prominence when
it was identified as the normal isoform of the disease-associated
protein (PrPSc) that accumulates in the brains of humans and
animals with transmissible spongiform encephalopathies (1).
That observation increased interest in the role of PrPC in neu-
rons. Reports that PrPC is concentrated at synapses (2, 3) and
that transgenic mice in which the gene for PrP had been
knocked-out (Prnp(0/0)) showed synaptic and memory deficits
(4, 5) suggest that it plays a role in neurotransmission. The
targeting of proteins to specific cellular locationsmay be critical
for their function. For example, the proteins involved in synap-
tic vesicle recycling need to be delivered to the synapse in neu-
rons. Little is known about the molecular mechanism(s) by
which PrPC accumulates within synapses. PrPC is linked to cell
membranes by a glycosylphosphatidylinositol (GPI) anchor (6),
which affects the cellular distribution and function of PrPC
(7–9). PrPC is found within cholesterol-rich, membrane
microdomains that are commonly called lipid rafts (10, 11).
Because only a small proportion of proteins that are found
within lipid rafts are subsequently transported to synapses, the
factors affecting the targeting of PrPC to synapses were studied.
The GPI anchor that links PrPC to the cell membrane targets
it to lipid rafts (7). There are many different lipid rafts that
demonstrate heterogeneity in their protein, glycolipid, and lipid
composition (12), and different GPI-anchored proteins are tar-
geted to different lipid rafts. For example, Thy-1 and PrPC
occupy separate domains on the neuronal surface (13).
Although all GPI anchors contain a conserved core, variations
on this core structure are common (14), and theGPI attached to
PrPC differs from that of Thy-1 (15, 16). It has been hypothe-
sized that the localization of some GPI-anchored proteins to
specific lipid rafts and hence specific cell membranes is due to
the composition of the GPI anchor. Thus, the composition of
GPI anchors directs antigens to different rafts in the absence of
interactive external domains (17, 18), and the chemical compo-
sition of the GPI anchor alters the intracellular trafficking of
proteins (19).ManyGPI-anchoredmolecules are rapidly incor-
porated into living cells (20, 21). In this study, PrPC was trans-
ferred to recipient cortical neurons derived from Prnp knock-
out(0/0) mice. We demonstrate that the targeting of PrPC to
synapseswas dependent upon cholesterol concentrations in the
recipient neurons. Critically, we also demonstrate that the
composition of the GPI anchor attached to PrPC is a key factor
that affects the targeting of PrPC to synapses. More specifically,
we show that the presence of sialic acid on the GPI anchor is
necessary for the targeting of PrPC to synapses.
Results
PrPC Is Targeted to Synapses—To study the factors that con-
trol the targeting of PrPC to synapses, PrPC (10 nM) was intro-
duced into neurons derived from Prnp(0/0) mice (22). PrPC
preparations run in gels and stained with Coomassie Brilliant
Blue did not show any contaminants (Fig. 1A). After 2 h, recip-
ient neurons were collected, and organelles were separated
upon a Percoll density gradient. The synaptic protein synapto-
physin, used to identify synaptosomes, was concentrated in
fractions 42–46 (Fig. 1B). These fractions also contained high
concentrations of the synaptic proteins synapsin-1 and synap-
tobrevin-1 and were consequently pooled as synaptosomes.
Following introduction to neurons, PrPC showed a time-depen-
dent (Fig. 1C) and concentration-dependent (Fig. 1D) accumu-
lation within synaptosomes. Not all GPI-anchored proteins
were targeted to synapses because GPI-anchored CD14 added
to neurons did not accumulate within synapses.
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Targeting of PrPC to Synapses Is Sensitive to Cholesterol
Depletion—PrPC is found in lipid rafts that contain high con-
centrations of cholesterol (11). Because cholesterol depletion
affects the expression of PrPC (7, 23, 24), the effects of choles-
terol depletion on the targeting of PrPC to synapses were exam-
ined. Prnp(0/0) neurons were treated with squalestatin, a selec-
tive squalene synthase inhibitor that reduced neuronal
cholesterol concentrations (25). Although treatment with 1M
squalestatin did not affect the uptake of exogenous PrPC into
neurons (9.3 nM PrPC 0.6 compared with 9.2 nM 0.5, n 9,
p  0.68), it significantly reduced the concentrations of PrPC
found in lipid rafts (detergent-resistant membranes (DRMs))
(Fig. 2A). Although cholesterol is required for the formation
and maintenance of synapses (26, 27), the mild cholesterol
depletion caused by 1M squalestatin did not significantly alter
the concentrations of synaptophysin, cysteine string protein
(CSP), synapsin-1, or VAMP-1 (vesicle-associated membrane
protein 1) in neurons (Fig. 2B) or isolated synaptosomes (Fig.
2C), indicating that it did not damage synapses.When Prnp(0/0)
neurons were treated with squalestatin for 24 h and incubated
with 10 nM PrPC, squalestatin caused a dose-dependent reduc-
tion in the concentrations of PrPC found within synaptosomes
(Fig. 2D). There was a significant correlation between choles-
terol concentrations in squalestatin-treated neurons and the
concentrations of PrPC found in synapses (Pearson’s coeffi-
cient 0.73, p 0.01) (Fig. 2E). Treatment of Prnp(/) wild-
type neurons with 500 nM squalestatin reduced the concentra-
tions of PrPC in synaptosomes (Fig. 2). The addition of 5 M
squalene reversed the effects of squalestatin upon neuronal
cholesterol concentrations (23) and PrPC trafficking to syn-
apses (Fig. 2G).
Monoacylated PrPC Is Not Targeted to Synapses—PrPC was
digested with PLA2, an enzyme that targets acyl chains con-
tained within GPIs to form monoacylated PrPC (Fig. 3B) and
isolated using an immunoaffinity column and reverse phase
chromatography as described (8). Although similar amounts of
monoacylated PrPC and PrPC bound to recipient Prnp(0/0) neu-
rons (9.4 nM PrPC  0.7 compared with 9.2 nM  0.5, n  12,
FIGURE 1. PrPC is targeted to the synapses. A, Coomassie Brilliant Blue-
stained gel showing protein ladder (lane 1) and neuronal PrPC (lane 2). B,
amounts of synaptophysin in fractions derived from Prnp(0/0) neurons sepa-
rated on a Percoll density gradient. Values are means S.D. (error bars) from
an experiment measured in quadruplicate. C, concentrations of PrPC () or
CD14 (f) in synaptosomes derived from Prnp(0/0) neurons incubated with 10
nM proteins for time periods as shown. Values are means S.D. from dupli-
cate experiments performed five times (n 10).D, concentrations of PrPC ()
or CD14 (f) in synaptosomes from Prnp(0/0) neurons incubatedwith proteins
as shown for 2 h. Values are means  S.D. from duplicate experiments per-
formed five times (n 10). FIGURE 2. Cholesterol depletion reduced the targeting of PrPC to syn-
apses. A, concentrations of PrPC in raft and non-raft membranes from
Prnp(0/0) neurons pretreated with a vehicle control () or 1 M squalestatin
(f) and incubatedwith 10 nMPrPC for 2 h. Values aremeans S.D. (error bars)
from triplicate experiments performed four times (n 12). *, raft PrPC signif-
icantly less than in control neurons. B, immunoblots showing the amounts of
synaptophysin, CSP, synapsin-1, and VAMP-1 in neurons incubated with
squalestatin as shown. C, immunoblotting showing the amounts of synaptic
proteins in synaptosomes treatedwith controlmedium (lane 1) or 1M squal-
estatin (lane 2).D, concentrations of PrPC in synaptosomes fromPrnp(0/0) neu-
rons pretreated with a vehicle control () or squalestatin as shown (f) and
incubated with 10 nM PrPC for 2 h. Values are means  S.D. from triplicate
experiments performed four times (n 12). *, synaptic PrPC significantly less
than in control neurons. E, there was a significant correlation between cho-
lesterol concentrations in Prnp(0/0) neurons treated with squalestatin (range
from1M to 125 nM) and the concentrations of PrPC in synaptosomes follow-
ing incubationwith 10 nM PrPC for 2 h (Pearson’s coefficient 0.73, p 0.01).
F, concentrations of PrPC in synaptosomes from Prnp(/) neurons treated
with a vehicle control () or 1M squalestatin (f) for 2 h. Values aremeans
S.D. from triplicate experiments performed three times (n 9). G, concentra-
tions of PrPC in synaptosomes from Prnp(0/0) neurons pretreated with a vehi-
cle control or 1 M squalestatin as shown (f) mixed with 5 M squalene
(checkered bars) and incubated with 10 nM PrPC for 2 h. Values are means
S.D. from triplicate experiments performed three times (n 9).
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p 0.3), they were differently distributed betweenmembranes.
Whereas the majority of PrPC was found within lipid rafts
(DRMs), most of the monoacylated PrPC was found within
detergent-solublemembranes (DSMs) (Fig. 3C). Monoacylated
PrPC added to Prnp(0/0) neurons was not targeted to synapto-
somes (Fig. 3D).
Glia-derived PrPCDidNot Target Synapses—Because PrPC is
also expressed by glial cells, we sought to determine whether
glia-derived and neuron-derived PrPC had the same properties.
Prnp(0/0) neurons were incubated with 10 nM glia-derived PrPC
or 10 nMneuron-derived PrPC for 2 h. Therewere no significant
differences in the concentrations of glial and neuronal PrPC
incorporated into recipient neurons; nor were there any signif-
icant differences in the concentrations found within DRMs
(Table 1). However, glial PrPC did not accumulate within syn-
aptosomes (Fig. 4A). By comparing neuron and glia-derived
PrPC we sought to determine the factors that affect synaptic
targeting. Because the glycosylation of PrPC affects the traffick-
ing of PrPC (28, 29), the possibility that cell-specific glycosyla-
tion affected the targeting of PrPC to synapses was examined.
PNGase removed the N-linked glycans from PrPC (30). When
Prnp(0/0) neurons were pulsed with 10 nM neuronal PrPC or 10
nM PNGase-digested neuronal PrPC for 2 h, we found that the
removal ofN-linked glycans did not alter the concentrations of
PrPC that bound to recipient neurons or the concentrations of
PrPC found within synaptosomes (Table 1 and Fig. 4B).
PNGase-digested glial PrPC was not found within synapto-
somes, indicating that N-linked glycans did not stop glial PrPC
from targeting synapses (Table 1). To eliminate the possible
effects ofN-linked glycans on the trafficking of PrPC, all subse-
quent experiments were carried out on PNGase-digested PrPC
preparations.
Because the composition of the GPI anchor is dependent
upon the cell type (31, 32), the nature of GPIs attached to glial
and neuronal PrPC was determined. Isolated GPIs from neuro-
nal and glial PrPC were blotted onto nitrocellulose mem-
branes. Detection with the phosphatidylinositol-reactive mAb
5AB3-11 andbiotinylated concanavalinA (which binds toman-
nose, a core component of all GPIs) showed that similar
amounts ofGPIswere loaded ontomembranes.However, Sam-
bucus nigra lectin (which reacts with terminal sialic acid bound
either -2,6 or -2,3 to galactose) bound to GPIs isolated from
FIGURE 3. Monoacylated PrPC is not targeted to synapses. Schematics
show the putative structure of the GPIs attached to PrPC (A) and monoacy-
lated PrPC (B). Glycan residues shown includemannose (Man), sialic acid (SA),
galactose (Gal),N-acetyl galactosamine (GalNAc), inositol (Inos), and glucosa-
mine (GlcN). C, concentrations of PrPC () and monoacylated PrPC (f) in raft
and non-raft membranes derived from Prnp(0/0) neurons incubated with 10
nM PrPC/monoacylated PrPC for 2 h. Values aremeans S.D. (error bars) from
triplicate experiments performed three times (n9).D, the concentrations of
PrPC in synaptosomesderived fromPrnp(0/0) neurons incubatedwithPrPC ()
or monoacylated PrPC (f) as shown for 2 h. Values are means  S.D. from
duplicate experiments performed five times (n 10).
TABLE 1
N-linked glycans do not affect the targeting of PrPC to synapses
The concentrations of PrPC in cell extracts, DRMs, DSMs, and synaptosomes iso-
lated fromPrnp(0/0) neuronswere incubatedwith 10 nMneuron-derived PrPC, 10 nM
PNGase-digested neuron-derived PrPC, 10 nM glia-derived PrPC, or 10 nM PNGase-
digested glia-derived PrPC for 2 h. Values are means S.D. from triplicate experi-
ments performed four times (n 12).
Concentration PrPC
Total DRM DSM Synapse
nM
Neuronal PrPC 9.2 0.9 8.5 0.8 1.0 0.4 1.8 0.32
PNGase-digested neuronal PrPC 8.9 0.6 8.2 0.8 0.9 0.3 1.9 0.35
Glial PrPC 9.2 1.0 8.6 0.8 1.1 0.3 0.29 0.24a
PNGase-digested glial PrPC 9.0 0.5 8.0 0.9 1.1 0.4 0.24 0.18a
a Concentration of PrPC in synaptosomes significantly less than in neurons incu-
bated with neuron-derived PrPC.
FIGURE 4.Glia-derived PrPC is not targeted to synapses. A, concentrations
of PrPC in synaptosomes from Prnp(0/0) neurons incubated for 2 h with neu-
ronal PrPC () or glial PrPC (hatched bars) as shown. Values are means S.D.
(error bars) from triplicate experiments performed three times (n 9). B, Coo-
massie Brilliant Blue-stained gel showing protein ladder (lane 1), deglycosy-
lated glial PrPC (lane 2), and deglycosylated neuronal PrPC (lane 3). C, concen-
trations of PrPC in synaptosomes from Prnp(0/0) neurons incubated for 2 h
with neuronal PrPC () or endoglycosidase F-digested neuronal PrPC (check-
ered bars) as shown. Values are means  S.D. from duplicate experiments
performed five times (n  10). D, dot blots showing the binding of mAb
5AB3-11 (phosphatidylinositol), concanavalin A (mannose), or S. nigra lectin
(sialic acid) to GPIs isolated from neuronal PrPC (lane 1) or glial PrPC (lane 2).
GPIs and Synaptic Targeting
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neuronal PrPC but not glial PrPC (Fig. 4C), indicating that only
the GPI attached to neuronal PrPC contained a terminal sialic
acid.
Desialylated PrPC Does Not Target Synapses—The composi-
tion of GPI anchors affects the targeting of proteins to specific
membranes (20, 33). This sialic acid on GPIs derived from neu-
ronal PrPC is susceptible to neuraminidase digestion (34),
resulting in desialylated PrPC (Fig. 5A). Digestion of neuronal
PrPC with neuraminidase reduced the binding of S. nigra lectin
without affecting the binding of concanavalin A or the
phosphatidylinositol-reactive mAb 5AB3-11. Neuraminidase
removal of terminal sialic acid would be expected to reveal a
galactose residue (Fig. 5A). The lectin RC1 (which reacts with
terminal galactose) binds to GPIs derived from desialylated
PrPC but not to GPIs from neuronal PrPC, consistent with the
putative structure of PrPC GPIs as proposed by Stahl et al. (15)
(Fig. 5B). Similar amounts of PrPC and desialylated PrPC bound
to Prnp(0/0) neurons and were found within DRMs (Table 1).
Although both neuronal and desialylated PrPC were targeted to
rafts, desialylated PrPC did not accumulate in synapses (Fig.
5C).
To determine whether the GPI attached to PrPC found at
synapses differed from that found in the cell body, synapto-
somes from Prnp(/) wild-type neurons were isolated. PrPC
was purified, and GPIs were isolated. There were no obvious
differences between GPIs isolated from synaptic PrPC or from
cell body PrPC when analyzed by high performance thin layer
chromatography (HPTLC) (Fig. 5D) or by dot blots (Fig. 5E).
The S. nigra lectin (which binds terminal sialic acid) bound to
GPIs isolated from PrPC derived from the cell body.
Isolated GPIs Are Targeted to Synapses—GPIs from neuronal
PrPC and desialylated PrPC were isolated on C18 columns (Fig.
6A) and HPTLC (Fig. 6B) and labeled with FITC. Prnp(0/0) neu-
rons were incubated with 10 nM FITC or 10 nM FITC-labeled
GPIs for 2 h and washed, and florescence was measured. Neu-
rons incubated with 10 nM FITC contained only 0.6 nM  0.2
FITC compared with neurons incubated with FITC-GPI (8.2
nM 0.88) or FITC-desialylated GPI (7.7 nM 0.98) (Table 2).
Similar concentrations of GPIs and desialylated GPIs were
found in lipid rafts (DRMs) (Table 2). GPIs derived from neu-
ronal PrPC accumulated in synaptosomes in a dose-dependent
manner (Fig. 6C). FITC-GPIs accumulated in synaptosomes at
higher concentrations than FITC alone or desialylated GPIs
(Fig. 6D).
To determine whether GPIs inhibited the targeting of neu-
ronal PrPC to synaptosomes, Prnp(0/0) neurons were pretreated
withGPIs derived fromPrPC (10 to 1.25 nM) and incubatedwith
10 nM neuronal PrPC for 2 h. These GPIs reduced the concen-
trations of PrPC found within synaptosomes in a dose-depen-
dent manner (Fig. 6E). This effect was structure-dependent
because desialylated GPIs did not affect the concentrations of
PrPC found within synaptosomes (Fig. 6F).
GPIs Target IgG to Synapses—To test the hypothesis that spe-
cific GPIs could target other proteins to synapses, rabbit IgG
was conjugated to GPIs (derived from neuronal PrPC) or desia-
lylated GPIs. The GPI-modified rabbit IgG was isolated by
reverse phase chromatography on C18 columns. IgG conju-
gated to GPIs or desialylated GPIs eluted from C18 columns in
concentrations between 60 and 70%, whereas control IgG did
not bind and eluted in the void volume (Fig. 7A). IgG conju-
gated to GPIs was differentiated from IgG by HPTLC (Fig. 7B).
Subsequently, neurons were incubated with 10 nM IgG, 10 nM
IgG-GPI, or 10 nM IgG-desialylated GPI for 2 h. Only low con-
centrations of IgG (0.3 nM) bound to neurons. Similar concen-
trations of IgG-GPI and IgG-desialylated GPI were found in
neurons, indicating that the composition of the GPI did not
affect the binding to neurons (Fig. 7C). Both IgG-GPI and IgG-
desialylated GPI were targeted to lipid rafts (DRMs) (Table 3).
Both were released from neurons by digestion with phosphati-
dylinositol-specific phospholipase C (PI-PLC), indicating that
they were expressed at the surface of neurons (Table 3). Criti-
cally, IgG-GPI, but not IgG-desialylated GPI, was found in syn-
aptosomes (Fig. 7D).
FIGURE 5.Desialylated PrPC is not targeted to synapses. A, putative struc-
ture of the GPI attached to neuronal PrPC after digestionwith neuraminidase.
B, dot blots showing thebindingofmAb5AB3-11 (phosphatidylinositol), con-
canavalin A (mannose), S. nigra lectin (sialic acid), or RC1 (galactose) to GPIs
isolated from PrPC (lane 1) and desialylated PrPC (lane 2). C, concentrations of
PrPC in synaptosomes from Prnp(0/0) neurons incubated for 2 h with PrPC ()
or desialylated PrPC (striped bars) as shown. Values are means  S.D. (error
bars) from triplicate experiments performed three times (n  9). D, GPIs
derived from neuronal PrPC isolated from synaptosomes (lane 1) or from the
cell body (lane 2) separated by HPTLC. E, dot blots showing the binding of
mAb 5AB3-11 (phosphatidylinositol), concanavalin A (mannose), or S. nigra
lectin (terminal sialic acid) to GPIs attached to PrPC isolated from synapto-
somes (lane 1) or from the neuronal cell body (lane 2).
GPIs and Synaptic Targeting
17096 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 33•AUGUST 12, 2016
 at Cam
bridge U
niversity Library on N
ovem
ber 14, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Discussion
Our study examined the factors that affect the distribution of
PrPC in neurons. We report that PrPC added to recipient
Prnp(0/0) neurons rapidly accumulated at synapses. The target-
ing of PrPC to synapses was dependent upon two key factors:
the cholesterol concentration of cell membranes and the com-
position of the GPI attached to PrPC. More specifically, PrPC
was not targeted to synapses following the removal of either
sialic acid or an acyl chain from the GPI attached to PrPC.
The targeting of proteins to specificmembrane domains is of
key importance in neurons. PrPC is concentrated in synapses (2,
3), and in this study, neuron-derived PrPC was targeted to syn-
apses after its inclusion in specific, cholesterol-sensitive, lipid
rafts. Themild cholesterol depletion caused by squalestatin did
not affect the number of synapses. However, this cholesterol
depletion reduced the targeting of neuronal PrPC to lipid rafts
and the trafficking of PrPC to synapses (there was a significant
correlation between the concentrations of cholesterol in squal-
estatin-treated neurons and the concentrations of PrPC found
within synaptosomes), results consistent with the hypothesis
that the inclusion of PrPC into lipid rafts precedes delivery of
PrPC to synapses. Squalestatin also reduced the concentrations
of PrPC found in synaptosomes from wild type neurons. The
effect of squalestatin on cholesterol concentrations and the tar-
geting of PrPC to rafts and synaptosomes were reversed by the
addition of squalene.
Wehypothesized that theGPI also targetedPrPC to synapses.
This hypothesis was supported by the observation that mono-
acylated PrPC was neither targeted to rafts nor found in syn-
FIGURE 7. Sialylated GPIs targeted IgG to synapses. A, concentrations of
IgG (f), IgG-GPI (●), or IgG-desialylated GPI () in fractions eluted off of C18
columns under a gradient of propanol and water. B, IgG (lane 1) and IgG-GPI
(lane 2) separated by HPTLC. C, concentrations of IgG in neurons incubated
with 10 nM IgG (), 10 nM IgG-GPI (f), or 10 nM IgG-desialylated GPI (striped
bar) for 2 h. Values are means S.D. (error bars) from triplicate experiments
performed three times (n  9). D, concentrations of IgG in synaptosomes
derived from neurons incubated with 10 nM IgG (), 10 nM IgG-GPI (f), or 10
nM IgG-desialylated GPI (striped bar) for 2 h. Values are means  S.D. from
triplicate experiments performed three times (n 9).
TABLE 2
GPIs are targeted to rafts
Shown are the concentrations of GPIs in Prnp(0/0) neurons incubated with 10 nM
FITC (as a control) or 10 nM FITC conjugated to GPI or desialylated GPI for 2 h
when cell extracts, DRMs, and DSMs were isolated. Values are means S.D. from
triplicate experiments performed 4 times (n 12).
FITC (Fluorescence)
Total DRM DSM
nM
FITC-control 0.6 0.2 0.2 0.2 0.4 0.2
FITC-GPI 8.2 0.88 7.6 0.64a 0.53 0.21
FITC-desialylated GPI 7.7 0.98 7.2 0.71a 0.51 0.25
a Concentration of GPIs in DRMs (rafts) significantly less than in neurons incu-
bated with control GPIs.
FIGURE 6. Desialylated GPIs do not target synapses. A, GPIs derived from
neuronal PrPC (E) and desialylated GPIs (●) eluted from C18 columns. Values
aremeansof duplicates.B, GPIs derived fromneuronal PrPC (lane 1) anddesia-
lylatedGPIs (lane 2) separated byHPTLC. C, amounts of FITC in synaptosomes
from neurons incubated for 2 h with FITC-labeled GPIs as shown. Values are
means S.D. (error bars) from triplicate experiments performed twice (n 6).
D, amounts of FITC in synaptosomes from neurons incubated for 2 h with 10
nM FITC alone () or with 10 nM FITC-labeled GPIs (f) or 10 nM FITC-desialy-
lated GPIs (striped bar). Values are means S.D. from triplicate experiments
performed twice (n 6). E, concentrations of PrPC in synaptosomes isolated
from Prnp(0/0) neurons pretreatedwith control medium () or GPIs as shown
(f) and incubated with 10 nM PrPC. Values are means  S.D. from triplicate
experiments performed two times (n  6). *, significantly less synaptic PrPC
than in control synaptosomes. F, concentrations of PrPC in synaptosomes
isolated from Prnp(0/0) neurons pretreated with control medium (), 10 nM
GPIs (f), or 10 nM desialylated GPIs (striped bar) and incubated with 10 nM
PrPC. Values are means  S.D. from triplicate experiments performed two
times (n 6). *, significantly less synaptic PrPC than in control synaptosomes.
GPIs and Synaptic Targeting
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apses. It is thought that saturated acyl chains attached to GPIs
allow tight molecular packing and increase the solubilization of
cholesterol (35, 36). Consequently, the loss of a saturated acyl
chain disrupts the membrane surrounding monoacylated PrPC
(8). Not all GPI-anchored proteins found within rafts are found
within synapses, and neither the GPI-anchored CD14 nor glial
PrPC was found within synaptosomes. The observation that
glial PrPC was not found within synapses indicated that the
essential synaptic targeting signal in PrPC lay in a post-transla-
tional modification. Because digestion with PNGase did not
affect the trafficking of PrPC to synapses, we concluded that
N-linked glycosylation of neuronal and glial PrPC was not a
significant factor in targeting PrPC to synapses.
The composition of the GPI anchor is dependent upon the
cell type (31, 32), and the structure of the GPI attached to PrPC
can vary (15).Whereas the GPI attached to neuronal PrPC con-
tains sialic acid, GPIs derived from glial PrPC did not, suggest-
ing that the presence of sialic acid on the GPI attached to neu-
ronal PrPC was a key factor that targeted it to synapses. This
hypothesis was supported by observations that the removal of
sialic acid from neuronal PrPC reduced its migration to syn-
apses. Notably, desialylated neuronal PrPC and glial PrPC had
similar properties; both targeted lipid rafts and were predomi-
nantly expressed at the surface of recipient neurons. The com-
position of GPI targets proteins to different lipid rafts (17, 33,
37) that traffic via different pathways (9, 19), indicating how the
composition of the GPI can affect the trafficking of PrPC. Thus,
whereas PrPC with a sialylated GPI enters a pathway that ends
at the synapse, desialylated PrPC targeted a different raft and
trafficked to a different cellular location.
GPI-anchored proteins are surrounded by lipid shells that
are dependent onmultiple protein-lipid, glycan-lipid, and lipid-
lipid interactions (38). The concept that the molecular struc-
ture of the GPI may regulate the composition of the underlying
membrane was supported by observations that Thy-1 and PrPC
have different GPI anchors (15, 16) and occupy separate
domains on the neuronal surface (13), which have different
lipid compositions (40). Similarly, desialylated PrPC is associ-
ated with membrane rafts containing greater concentrations of
gangliosides and cholesterol than native PrPC (41). It is note-
worthy that gangliosides help sequester cholesterol and stabi-
lize rafts (42–44) and affect the distribution and trafficking of
GPI-anchored proteins (45, 46), including PrPC (47). The
increased association of desialylated PrPC with gangliosides
helps explain why desialylated PrPC showed greater resistance
to cholesterol depletion than did neuronal PrPC.
These results suggested that the synapse-targeting informa-
tion is contained within the GPI alone, which is consistent with
reports that the glycan composition of GPIs direct antigens to
specific membrane microdomains in the absence of interactive
external domains (18, 33). The targeting of isolated GPIs
(derived from PrPC) also required the presence of sialic acid.
The role of the GPI as a major “synapse-targeting” signal was
demonstrated when isolated GPIs were conjugated to rabbit
IgG. IgGwas not readily taken up by neurons andwas not found
within synapses. In contrast, IgG conjugated to GPIs derived
from neuronal PrPC inserted into recipient neurons and was
targeted to synapses. Although IgG conjugated to desialylated
GPIs also inserted into neurons, it was not found within syn-
apses. Such results suggest a novel mechanism of cell engineer-
ing whereby proteins could be targeted to synapses by the
attachment of specific GPIs.
The maximum concentration of PrPC measured in synapses
of recipient neurons, regardless of how much PrPC was added,
was2 nM. Similar concentrations of PrPC were found in syn-
aptosomes from Prnp wild-type neurons, suggesting that the
process bywhichPrPC traffics to synapses is limited. In a similar
manner, the concentrations of isolated GPIs found at synapses
were also limited. The observation that pretreatment with iso-
lated GPIs reduced the targeting of neuronal PrPC to synapses
supported the hypothesis that PrPC and isolated GPIs compete
for the same synapse-targeting pathways. This hypothesis is
supported by the observation that the capacity of GPIs to block
the targeting of neuronal PrPC to synapses was also dependent
upon the presence of sialic acid.
In conclusion, we demonstrated the role of GPIs as targeting
signals in neurons. The targeting of PrPC to synapses was de-
pendent upon the structure of the GPI anchor requiring the
presence of two acyl chains and sialic acid. The composition of
theGPI anchor alone contained sufficient information to target
synapses in the absence of the external protein domain.
Experimental Procedures
Primary Neuronal Cultures—Cortical neurons were pre-
pared from the brains of mouse embryos (day 15.5) from both
Prnp wild-type(/) and Prnp knock-out(0/0) mice. Neurons
were plated at 1 106 cells/well in 6-well plates (precoatedwith
poly-L-lysine) in Ham’s F-12 containing 5% fetal calf serum for
2 h. Cultures were then shaken (600 rpm for 5 min), and non-
adherent cells were removed by three washes in PBS. Neurons
were grown in neurobasalmediumcontainingB27 components
and nerve growth factor (5 ng/ml) (Sigma) for 10 days. Immu-
nohistochemistry showed that the cells were greater than 95%
neurofilament-positive. For cell-targeting studies, neurons
were incubated with PrPC preparations for different time peri-
ods. In some experiments, neurons were pretreated with test
compounds (drugs, PrP preparations, and isolated GPIs) and
incubated with test preparations.
Cell Extracts—Neurons were homogenized in an extraction
buffer containing 150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 10
mM EDTA, 0.5% Nonidet P-40, 0.5% sodium deoxycholate,
0.2% SDS, and mixed protease inhibitors (4-(2-aminoethyl)
benzenesulfonyl fluoride hydrochloride, aprotinin, leupeptin,
bestatin, pepstatin A, and E-46) (Sigma) and a phosphatase
TABLE 3
Sialylated GPIs target IgG to rafts
Shown are the concentrations of rabbit IgG in neurons incubated with 10 nM rabbit
IgG (as a control), 10 nM rabbit IgG-GPI, or 10 nM IgG-desialylatedGPI for 2 hwhen
cell extracts, DRMs, andDSMswere collected. Also shown are the concentrations of
IgG in neurons following digestion with PI-PLC. Values are means  S.D. from
triplicate experiments performed four times (n 12).
Rabbit IgG
Total DRM DSM PI-PLC
nM
Control IgG 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1
IgG-GPI 9.1 0.4 8.4 0.5 0.8 0.2 0.2 0.2
IgG-desialylated GPI 9.2 0.5 8.5 0.7 0.8 0.2 0.1 0.1
GPIs and Synaptic Targeting
17098 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 33•AUGUST 12, 2016
 at Cam
bridge U
niversity Library on N
ovem
ber 14, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
inhibitor mixture including PP1, PP2A, microcystin LR, can-
tharidin, and p-bromotetramisole (Sigma) at 106 cells/ml.
Nuclei and cell debris were removed by centrifugation (500 g
for 5 min).
Isolation of Synaptosomes—Synaptosomes were prepared on
a discontinuous Percoll gradient as described (48). Briefly, neu-
rons were homogenized at 4 °C in 1 ml of SED solution (0.32 M
sucrose, 5 mM Tris-HCl, pH 7.2, 1 mM EDTA, and 0.25 mM
dithiothreitol) and centrifuged at 1000  g at 4 °C. The super-
natant was transferred to a four-step gradient of 3, 7, 15, and
23%Percoll in SED solution and centrifuged at 16,000 g for 30
min at 4 °C. The synaptosomes were collected from the inter-
face between the 15 and 23%Percoll andwashed (16,000 g for
10 min at 4 °C) and suspended in neurobasal medium contain-
ing B27 components. All synaptosomes were used on the same
day of preparation; freshly prepared synaptosomes were incu-
bated with peptides for 1 h. After the test period, synaptosomes
were homogenized in either extraction buffer (as above) or in
the DRM extraction buffer (as below). All synaptosome prepa-
rations contained equal amounts of synaptophysin.
Western Blotting—Samples were mixed with Laemmli buffer
containing -mercaptoethanol and heated to 95 °C for 5 min,
and proteins were separated by electrophoresis on 15% poly-
acrylamide gels. Proteins were transferred onto a Hybond-P
polyvinylidene fluoride membrane by semidry blotting. Mem-
branes were blocked using 10% milk powder; synapsin-1 was
detectedwith goat polyclonal antibody (SantaCruzBiotechnol-
ogy), synaptophysin with MAB368 (Abcam), CSP with rabbit
polyclonal anti-CSP (sc-33154, Santa Cruz Biotechnology),
VAMP-1 withmAb 4H302 (Abcam), caveolin with rabbit poly-
clonal antibodies to caveolin (Upstate), and PrPCwithmAb 4F2
(J. Grassi). These were visualized using a combination of bioti-
nylated anti-mouse/goat/rat/rabbit IgG (Sigma), extravidin-
peroxidase, and enhanced chemiluminescence.
Isolation of DRMs—These membranes were isolated by their
insolubility in non-ionic detergents as described (49). Briefly,
samples were homogenized in an ice-cold buffer containing 1%
Triton X-100, 10 mM Tris-HCl, pH 7.2, 150 mM NaCl, 10 mM
EDTA, and mixed protease and phosphatase inhibitors, and
nuclei and large fragments were removed by centrifugation
(300  g for 5 min at 4 °C). The postnuclear supernatant was
incubated on ice (4 °C) for 1 h with intermittent shaking and
centrifuged (16,000  g for 30 min at 4 °C). The supernatant
was reserved as the DSM, whereas the pellet was homogenized
in an extraction buffer (as above) and centrifuged (10 min at
16,000 g), and the soluble material was reserved as the DRM
fraction.
Synaptophysin ELISA—The amounts of synaptophysin in
neurons were measured by ELISA (50). Maxisorb immuno-
plates were coated with 0.5 g/ml mouse anti-synaptophysin
mAb (MAB368, Chemicon, Darmstadt, Germany) and blocked
with 5% milk powder. Samples were added for 1 h, and bound
synaptophysin was detected with rabbit polyclonal anti-synap-
tophysin (Abcam) followed by biotinylated anti-rabbit IgG,
extravidin-alkaline phosphatase, and 1 mg/ml 4-nitrophenol
phosphate (Sigma). Absorbance was measured on a microplate
reader at 405 nm. Samples were expressed as “units of synapto-
physin,” where 100 units was defined as the amount of synap-
tophysin in 106 control neurons.
Cholesterol—The concentrations of cholesterol in samples
were measured using the Amplex Red cholesterol assay kit
(Invitrogen) according to the manufacturer’s instructions.
Briefly, cholesterol was oxidized by cholesterol oxidase to yield
hydrogen peroxide and ketones. The hydrogen peroxide
reacted with 10-acetyl-3,7-dihydroxyphenoxazine (Amplex
Red reagent) to produce highly fluorescent resorufin, which
was measured by excitation at 550 nm and emission detection
at 590 nm.
Isolation of PrPC—PrPC molecules were isolated from neu-
rons or from N9 glial cells that had been homogenized in an
extraction buffer (as above), and cell debris and nuclei were
removed by centrifugation. The postnuclear supernatant was
incubated with an affinity column loaded with mAb ICSM35
(M. Tayebi), and PrPC was eluted using glycine-HCl at pH 2.7,
neutralized with 1 M Tris, and desalted. These PrPC prepara-
tions were further purified using size exclusion chromatogra-
phy (Superdex 200 PC column). Some PrPC preparations were
digested with 2 units/ml endoglycosidase F (Elizabethkingia
meningoseptica), 0.2 units/ml PI-PLC (Bacillus cereus), 10
units/ml bee venomPLA2, or 0.2 units/ml neuraminidase (Clos-
tridium perfringens) (all from Sigma) for 2 h at 37 °C. Samples
were centrifuged through a 50-kDa filter to remove enzymes,
and samples were loaded onto C18 columns (Waters). Proteins
were purified using reverse phase chromatography with a gra-
dient of propanol in water. Fractions were tested by ELISA;
PrP-containing fractions were pooled, desalted, and stored at
80 °C. For bioassays, samples were thawed on the day of use
and solubilized in culture medium by sonication.
PrP ELISA—The concentrations of PrP in samples were
determined by ELISA as described (8). Briefly,Maxisorb immu-
noplates were coated with mAb ICSM18 and blocked with 5%
milk powder. Samples were applied and detected with biotiny-
lated mAb ICSM35, followed by extravidin-alkaline phospha-
tase and 1 mg/ml 4-nitrophenyl phosphate. Absorbance was
measured on amicroplate reader at 405 nm, and the amount of
PrP in samples was calculated by reference to a standard curve
of recombinant murine PrP (Fisher).
Isolation of CD14—CD14was isolated fromN9glial cells that
had been homogenized in an extraction buffer (as above). Insol-
uble debris andnucleiwere removedby centrifugation.CD14 in
the postnuclear supernatant was isolated using an affinity col-
umn loaded with rat anti-mouse CD14 mAb (clone RmC5-3)
(BD Biosciences). CD14 was eluted with glycine-HCl at pH 2.7,
neutralized with 1 M Tris, and loaded onto C18 columns. Pro-
teins were eluted under a gradient of acetonitrile in water and
0.1% TFA. Fractions were tested by ELISA, and CD14-contain-
ing fractions were pooled, lyophilized, and stored at 80 °C.
For bioassays, samples were thawed on the day of use and sol-
ubilized in culture medium by sonication.
CD14 ELISA—Concentrations of CD14 were measured by
ELISA as described (39). Briefly, Maxisorb immunoplates were
coated with 0.5 g/ml rat IgG1 anti-mouse CD14 mAb (clone
RmC5-3). Sampleswere applied, and boundCD14was detected
using a goat polyclonal IgG anti-mouse CD14 (R&D Systems),
followed by anti-goat IgG conjugated to alkaline phosphatase
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(Sigma) and 1 mg/ml 4-nitrophenyl phosphate. Absorbance
was measured on a microplate reader at 405 nm and com-
pared with a titration of recombinant mouse CD14 (Enzo
Lifesciences).
Isolation and Analysis of GPI Anchors—PrPC preparations
were digested with 100 g/ml proteinase K for 24 h at 37 °C,
resulting in GPI anchors attached to the terminal amino acid.
The released GPIs were extracted with water-saturated butan-
1-ol and washed with water a further three times before being
loaded ontoC18 columns.GPIswere eluted using reverse phase
chromatography under a gradient of acetonitrile and water.
GPIswere detected by ELISA (see below), and positive fractions
were pooled and lyophilized. Stock solutions were dissolved in
ethanol at 2 M. For some experiments, isolated GPIs were
conjugated to FITC using the free amino group on the remain-
ing amino acid and the homobifunctional cross-linking agent
dimethyl pimelimidate (Fisher) using the manufacturer’s
instructions. Stock solutions were diluted in tissue culture
medium for bioassays. GPIs were detected by immunoblotting
as described with a mAb to phosphatidylinositol (34). The con-
centrations of FITC-labeledGPIs in samples were calculated by
measuring fluorescence, excitation at 490 nm, and emission at
525 nm and compared with a dose response of FITC. Extracted
GPIs were applied to silica gel 60 HPTLC plates (Whatman)
and developed using a mixture of chloroform/methanol/water
(4:4:1, v/v/v). Plates were soaked in 0.1% polyisobutyl methac-
rylate in hexane, dried, and blocked with 5% milk powder and
probed with 1 g/ml of mAb 5AB3-11, followed by biotiny-
lated anti-mouse IgM and extravidin-horseradish peroxidase
(Sigma), and visualized using chemiluminescence.
GPI ELISA—Maxisorb immunoplates were coated with 0.5
g/ml concanavalin A (which binds mannose) and blocked
with 5% milk powder in PBS-Tween. Samples were added, and
any bound GPI was detected by the addition of the phosphati-
dylinositol-reactive mAb 5AB3-11, followed by a biotinylated
anti-mouse IgM (Sigma), extravidin-alkaline phosphatase, and
1 mg/ml 4-nitrophenyl phosphate. Absorbance was measured
at 405 nm.
Lectin Analysis of GPI Anchors—The presence of specific gly-
cans in GPI anchors was determined using biotinylated lectins
and dot blotting as described (34). Isolated GPIs were blotted
onto nitrocellulose membranes, which were blocked (10%milk
powder). Samples were incubated with biotinylated S. nigra
(which detects terminal sialic acid residues bound -2,6 or
-2,3 to galactose) or biotinylated concanavalin A to detect
mannose (Vector Laboratories). Bound biotinylated lectins
were visualized using extravidin peroxidase and enhanced
chemiluminescence. The presence of phosphatidylinositol in
GPIs was determined using mAb (5AB3-11), which was visual-
ized using a horseradish peroxidase-conjugated anti-murine
IgG and chemiluminescence.
Conjugation of GPIs to Rabbit IgG—Rabbit IgG (Sigma) was
conjugated to GPIs by a two-step process. First, GPIs were con-
jugated to protein A (Innova Biosciences). The protein A com-
plex was then cross-linked to rabbit IgG, and both steps used
the homobifunctional cross-linking agent dimethyl pimelimi-
date (Pierce) according to themanufacturer’s instructions. IgG-
GPI conjugates were purified using reverse phase chromatog-
raphy on C18 columns. The concentrations of rabbit IgG in
samples were measured by ELISA. Maxisorb immunoplates
were coated withmAb anti-rabbit IgG, clone L27A9 (New Eng-
land Biolabs) and blocked with 5% milk powder. Samples were
added, and rabbit IgG was detected with biotinylated goat anti-
rabbit IgG (Sigma) followed by extravidin-alkaline phosphatase
and 1 mg/ml 4-nitrophenyl phosphate. Absorbance was mea-
sured on a microplate reader at 405 nm, and the amount of
rabbit IgG in samples was calculated by reference to a standard
curve of rabbit IgG (Sigma). IgG and IgG-GPI conjugates were
separated byHPTLC on silica gel 60 plates and developed using
a mixture of chloroform/methanol/water (4:4:1, v/v/v).
Statistical Methods—Comparison of treatment effects was
carried out using Student’s paired t tests and one-way and two-
way analysis of variance with Bonferroni’s post hoc tests (IBM
SPSS Statistics version 20). Error values are S.D., and signifi-
cance was determined where p was 0.01. Correlations
between data sets were analyzed using Pearson’s bivariate coef-
ficient (IBM SPSS Statistics version 20).
Author Contributions—C. B., W. N., and H. M.-O. were responsible
for carrying out the experiments and data analysis. C. B. and A. W.
were responsible for planning experiments and writing the
manuscript.
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